2nd Quarter - Report

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of H.R.5376 - Inflation Reduction Act of 2022 and potential reforms involving the treatment of orphan drugs. H.R.5539 - ORPHAN Cures Act. Medicaid Drug Rebate rule.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 5539 (118th), H.R. 5376 (118th)

Health Issues HCR

Issues related to about insurance coverage of specialty treatments. H.R.830 - HELP Copays Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 830 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.